Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 7, 2026
Reporting period
Not applicable
Filed with the SEC
May 11, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-005112
Filed / recorded
May 11, 2026, 8:33 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BOSTON SCIENTIFIC CORP
Issuer CIK
885725
Ticker
BSX
Reporting person
Cathy R Smith
Relationship
Director
Security
Deferred Stock Units
Table
Derivative (Table II)
Transaction date
May 7, 2026
Transaction code
A
Shares / units
2,209
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
6,888
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.
Congressional trade